Leukocyte adhesion molecules, such as intercellular adhesion molecule (ICAM
)-1 and its ligands, are involved in inflammatory processes of the lung. Fo
r ICAM-1, differential expression during different kinds of complications a
fter transplantation has been proposed.
We analyzed the role of ICAM-1, CD18, CD11a, CD11b, and CD11c during episod
es of rejection or infection in patients after lung transplantation and com
pared the results to episodes without apparent complication. A total of 98
bronchoalveolar lavage (BAL) samples and 90 serum samples were analyzed.
ICAM-1, CD18, CD11a, CD11b, and CD11c expressions were detected immunocytoc
hemically on alveolar macrophages. Soluble ICAM-1 was quantified in serum a
nd BAL. In the control group, 49.8 +/- 18% of macrophages stained positive
for CD11b. During rejection, the mean of cells showing CD11b on the surface
was significantly higher (64.6 +/- 11.4%), with no difference compared to
episodes of infection (59.7 +/- 22.7). All other epitopes were not expresse
d differently with regard to a normal clinical course or episodes of infect
ion and rejections.
In summary, assessment of ICAM-1 and corresponding ligands did not allow fo
r a reliable discrimination between episodes of rejection or infection in l
ung transplantation.